Quest Analytics Receives Renewed CMS Contract to Measure Network Adequacy for Medicare Advantage, Pharmacy Plans

Quest Analytics,the leader in provider network design and management solutions, announced today that the Centers for Medicare & Medicaid Services (CMS) has renewed their contract with Quest Analytics for an additional five-year term. The renewed agreement builds on an almost two-decade long partnership that has driven innovation in network adequacy and accuracy measurement. https://mma.prnewswire.com/media/1162215/Quest_Analytics_updated_Logo.jpg Since […]

Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of Marex Group Plc – MRX

NEW YORK CITY, NY / ACCESS Newswire / December 2, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company GlobeNewswire December 02, 2025 BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it intends to develop its fully human anti-IL-6 receptor (IL-6R) monoclonal antibody,

Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook

Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook GlobeNewswire December 02, 2025 VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (“Hydreight” or the “Company”) is pleased to provide a corporate update following its recently released Q3 financial results and investor webinar. On November 26, 2025, Hydreight

Nano Labs Announces Annual General Meeting

Nano Labs Announces Annual General Meeting GlobeNewswire December 02, 2025 HONG KONG, Dec. 02, 2025 (GLOBE NEWSWIRE) — Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, today announced that it will hold its 2025 Annual General Meeting of Shareholders (the “2025 Annual Meeting”)

Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation

Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation GlobeNewswire December 02, 2025 Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12 weeks observed after a single 180mg dose of Briquilimab in the ETESIAN Study Preliminary data from ETESIAN

NevGold Intercepts Highest-Grade Oxide Antimony At Bullet Zone Discovery: 5.51% Antimony Over 4.6 Meters Within 4.00 g/t AuEq Over 41.1 Meters (0.96% Antimony And 0.29 g/t Au) at Limo Butte, Nevada

NevGold Intercepts Highest-Grade Oxide Antimony At Bullet Zone Discovery: 5.51% Antimony Over 4.6 Meters Within 4.00 g/t AuEq Over 41.1 Meters (0.96% Antimony And 0.29 g/t Au) at Limo Butte, Nevada GlobeNewswire December 02, 2025 Vancouver, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company“) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased

Village Farms International Reaffirms its Commitment to the Texas Cannabis Industry

Village Farms International Reaffirms its Commitment to the Texas Cannabis Industry GlobeNewswire December 02, 2025 Outcome of conditional license awards has zero impact on Company's financial performance, outlook or strategy Company believes that its operating capabilities and infrastructure are well suited to support a viable industry in Texas MARFA, Texas, Dec. 02, 2025 (GLOBE NEWSWIRE)

Scroll to Top